HOUSE_OVERSIGHT_024664.jpg
1.22 MB
Extraction Summary
2
People
6
Organizations
2
Locations
1
Events
1
Relationships
2
Quotes
Document Information
Type:
Investment report / industry analysis
File Size:
1.22 MB
Summary
This document is page 28 of a Cannabis Investment Report dated December 2017 by Ackrell Capital. It details the science of cannabis genetics, propagation, and cloning methods (clipping vs. tissue culture), mentioning specific researchers Jon Page and Timothy Hughes who mapped the genome of the 'Purple Kush' variety in 2011. The document bears a 'HOUSE_OVERSIGHT_024664' Bates stamp, suggesting it was part of a document production for a congressional investigation, likely related to financial records or investment portfolios reviewed during the Epstein probes.
People (2)
| Name | Role | Context |
|---|---|---|
| Jon Page | Botanist |
Led a team from the National Research Council Canada to map the cannabis genome in 2011.
|
| Timothy Hughes | Scientist |
Researcher from the University of Toronto who sequenced genes in a sativa variety.
|
Organizations (6)
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC |
Author/Publisher of the report.
|
|
| National Research Council Canada |
Organization associated with Jon Page.
|
|
| University of Toronto |
Organization associated with Timothy Hughes.
|
|
| FINRA |
Regulatory body mentioned in footer.
|
|
| SIPC |
Regulatory body mentioned in footer.
|
|
| House Oversight Committee |
Implied by the Bates stamp 'HOUSE_OVERSIGHT'.
|
Timeline (1 events)
2011
Relationships (1)
Worked together on mapping the cannabis genome in 2011.
Full Extracted Text
Complete text extracted from the document (1,817 characters)
ACKRELL
CAPITAL
Cannabis Investment Report | December 2017
CAPITAL
Cannabis Investment Report | December 2017
for social anxiety disorders containing CBD, limonene and linalool; and sleeping medicines combining CBD, THC, caryophyllene, linalool and myrcene.
Genetics and Propagation
Selective breeding and other botanical techniques are being used to develop cannabis varieties with desired profiles of compounds, and scientists are developing tools to synthesize isolated cannabinoids in laboratory settings in order to study cannabis at the genetic level. For example, the first mapping of a cannabis genome was completed in 2011 by a team of Canadian botanists, led by Jon Page from the National Research Council Canada and Timothy Hughes from the University of Toronto, who sequenced 30,000 genes in a sativa variety named "Purple Kush."
Selective breeding and other botanical techniques are being used to develop cannabis varieties with desired profiles of compounds, and scientists are developing tools to synthesize isolated cannabinoids in laboratory settings in order to study cannabis at the genetic level. For example, the first mapping of a cannabis genome was completed in 2011 by a team of Canadian botanists, led by Jon Page from the National Research Council Canada and Timothy Hughes from the University of Toronto, who sequenced 30,000 genes in a sativa variety named "Purple Kush."
[Diagram: Chemical structure pathway showing Olivetolic acid -> Cannabigerolic acid -> THCA/CBDA -> THC/CBD]
Aromatic Prenyltransferase
THCA Synthase
CBDA Synthase
Non-enzymatic conversion (-CO2)
Cannabis Genome
Aromatic Prenyltransferase
THCA Synthase
CBDA Synthase
Non-enzymatic conversion (-CO2)
Cannabis Genome
Genetic copies, or "clones," of cannabis plants are generally produced using two methods, "clone clipping" and micropropagation, or "tissue culture." Clone clipping involves cutting a growing tip from a cannabis plant that is several inches long and inserting the cut tip into a growing medium, where it then grows into a new plant. Tissue culture involves taking a small tissue sample (which may even be a single cell) from a plant and growing it temporarily in a sterile nutrient solution before transferring it to a permanent growing medium. Controlling cannabis plant genomes is expected to be an important intellectual property issue in the cannabis industry (at least one U.S. patent has been issued for a strain of cannabis).
28
© 2017 Ackrell Capital, LLC | Member FINRA / SIPC
© 2017 Ackrell Capital, LLC | Member FINRA / SIPC
HOUSE_OVERSIGHT_024664
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document